Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
Monster Beverage
MNST
|
$396M |
| 5 |
argenx
ARGX
|
$306M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Starbucks
SBUX
$100B
| $510M | 0.34% | 4,898,343 +172,100 | +4% | +$17.9M |
|
77
Cadence Design Systems
CDNS
$95.5B
| $510M | 0.34% | 2,425,282 -35,356 | -1% | -$7.43M |
|
78
Analog Devices
ADI
$124B
| $505M | 0.33% | 2,559,428 -23,754 | -0.9% | -$4.68M |
|
79
Constellation Brands
STZ
$28.5B
| $503M | 0.33% | 2,228,483 +14,331 | +0.6% | +$3.24M |
|
80
Dayforce
DAY
$11B
| $490M | 0.32% | 6,692,822 +383,740 | +6% | +$28.1M |
|
81
Stryker
SYK
$150B
| $490M | 0.32% | 1,715,102 +355,205 | +26% | +$101M |
|
82
Humana
HUM
$36.5B
| $489M | 0.32% | 1,007,948 +122,205 | +14% | +$59.3M |
|
83
Crown Holdings
CCK
$11.6B
| $488M | 0.32% | 5,904,289 -538,917 | -8% | -$44.6M |
|
84
Broadridge
BR
$29.9B
| $484M | 0.32% | 3,301,755 +152,428 | +5% | +$22.3M |
|
85
Sensata Technologies
ST
$4.74B
| $478M | 0.32% | 9,553,161 -11,075 | -0.1% | -$554K |
|
86
Bank of America
BAC
$376B
| $459M | 0.3% | 16,060,816 +284,619 | +2% | +$8.14M |
|
87
Honeywell
HON
$139B
| $447M | 0.3% | 2,341,422 -330,718 | -12% | -$63.2M |
|
88
ConocoPhillips
COP
$124B
| $441M | 0.29% | 4,449,690 +279,757 | +7% | +$27.8M |
|
89
Vertex Pharmaceuticals
VRTX
$100B
| $431M | 0.28% | 1,366,712 -18,764 | -1% | -$5.91M |
|
90
Lamar Advertising Co
LAMR
$12.9B
| $429M | 0.28% | 4,297,320 +27,019 | +0.6% | +$2.7M |
|
91
Steris
STE
$24.1B
| $425M | 0.28% | 2,223,658 -88,974 | -4% | -$17M |
|
92
Adobe
ADBE
$151B
| $423M | 0.28% | 1,096,534 +307,505 | +39% | +$118M |
|
93
ICU Medical
ICUI
$3.15B
| $422M | 0.28% | 2,560,869 +3,643 | +0.1% | +$601K |
|
|
MMP
94
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $420M | 0.28% | 7,736,550 | – | – |
|
95
W.R. Berkley
WRB
$27.2B
| $418M | 0.28% | 6,714,303 -334,288 | -5% | -$20.8M |
|
|
96
Sherwin-Williams
SHW
$91.2B
| $411M | 0.27% | 1,828,278 -1,373,101 | -43% | -$309M |
|
97
Hilton Worldwide
HLT
$64.9B
| $402M | 0.26% | 2,852,132 +34,619 | +1% | +$4.88M |
|
98
Dollar General
DG
$23.9B
| $395M | 0.26% | 1,877,043 +291,481 | +18% | +$61.3M |
|
99
Chevron
CVX
$324B
| $384M | 0.25% | 2,351,446 +1,074,098 | +84% | +$175M |
|
100
Globus Medical
GMED
$8.27B
| $379M | 0.25% | 6,689,590 +1,055,636 | +19% | +$59.8M |
|